跳至主要内容
临床试验/IRCT20160717028967N7
IRCT20160717028967N7尚未招募2 期

The efficacy of duloxetinein the treatment of depression, withdrawal symptoms, craving for methamphetamine compared with placebo (clinical trial with a control group)

Kermanshah University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Male

入选标准

  • Gender Male
  • Methamphetamine dependence diagnoses accordingly Diagnostic and Statistical Manual of Mental Disorders fifth edition
  • The dominant use of methamphetamine for at least 6 months
  • lack of serious psychiatric disorders

排除标准

  • subjects who met opiates dependence
  • non compliance or not willing for continuing the study
  • sever and unbearable drug side effect even after reducing the dose.

研究者

相似试验